Insurance Industry Groups Backed Marijuana Coverage Bill

A coalition of national trade groups now supports federal legislation that protects insurers providing coverage to state-legalized cannabis businesses.

Updated on Sept. 22, 2026 in Insurance

Bold flat-color editorial illustration showing a brass padlock securing a latch, evoking legal protection and regulatory security. — Nine national insurance associations have endorsed the CLAIM Act, a bill designed to protect insurers working with state-legalized cannabis businesses from federal penalties. AI Illustration. Upload story photo >

Live Poll

Should federal law be adjusted to protect businesses operating in state-legalized industries from federal penalties?

Nine national insurance trade associations have endorsed the Clarifying Law Around Insurance of Marijuana (CLAIM) Act. This legislation would shield insurers and their employees from federal penalties for covering state-licensed cannabis businesses.

Why it matters

Insurers currently face conflicting obligations between federal and state laws, which can limit coverage options for individuals and businesses operating in legalized markets. This measure aims to provide legal certainty for the market while preserving state-level regulation.

This is the fourth consecutive Congress to see the introduction of the CLAIM Act, currently tracked as H.R.10471 in the House. Projections indicate this legislation could increase insurance product access for consumers with ties to state-legalized cannabis.

The players

GAO

The Government Accountability Office serves as a non-partisan federal watchdog that investigates how government funds are spent and studies complex policy issues.

The details

The bill creates a safe harbor for insurers, brokers, and agents, explicitly barring federal regulators from penalizing providers for working with cannabis-related businesses. Additionally, the legislation prohibits the termination of insurance policies based solely on a client's status as a cannabis business. It also mandates a GAO study on marketplace barriers for minority-owned and women-owned cannabis firms.

A Senate companion bill was filed earlier in 2026.
The Attorney General reclassified medical cannabis to Schedule III in April 2026.
The House version of the CLAIM Act, H.R.10471, was introduced the week of September 15, 2026.

Money Landscape

This legislative push follows the federal reclassification of medical cannabis to Schedule III in April 2026. The move signals an ongoing effort to bridge the gap between state-legalized industries and federal regulatory frameworks.

If you operate or have interests in state-legalized cannabis businesses, this bill could eventually lead to greater access to insurance products. Discuss the potential implications of shifting cannabis insurance laws with a qualified financial or tax professional as the legislative process evolves.

The takeaway

The insurance industry is seeking a clear legal framework to serve the cannabis sector without the threat of federal intervention. Watch for updates on H.R.10471 as it moves through the current session of Congress to see if it secures the necessary support to become law.